Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Breast Neoplasms 52Carcinoma, Renal Cell 47Neoplasm Metastasis 24Neoplasms 18Kidney Neoplasms 18Neuroendocrine Tumors 17Carcinoma, Non-Small-Cell Lung 13Tuberous Sclerosis 12Stomach Neoplasms 12Lymphoma, Mantle-Cell 12Lymphoma, Large B-Cell, Diffuse 11Recurrence 10Prostatic Neoplasms 10Lymphoma 10Hodgkin Disease 10Glioblastoma 10Colorectal Neoplasms 10Precursor Cell Lymphoblastic Leukemia-Lymphoma 9Brain Neoplasms 9Lymphoma, Follicular 8Lung Neoplasms 8Leukemia, Lymphocytic, Chronic, B-Cell 8Carcinoma 8Waldenstrom Macroglobulinemia 7Triple Negative Breast Neoplasms 7Sarcoma 7Multiple Myeloma 7Lymphoma, B-Cell, Marginal Zone 7Glioma 7Central Nervous System Neoplasms 7

Interventions

Doxorubicin 11Ifosfamide 9Radiotherapy 6Filgrastim 4pegfilgrastim 3Sorafenib 2Sirolimus 2Magnetic Resonance Spectroscopy 2Imatinib Mesylate 2Etoposide 2Chemotherapy, Adjuvant 2temsirolimus 1selinexor 1romidepsin 1ribociclib 1perifosine 1pazopanib 1lorvotuzumab mertansine 1liposomal doxorubicin 1indolepropanol phosphate 1exatecan 1cixutumumab 1brostallicin 1X-Rays 1Watchful Waiting 1Trabectedin 1Sunitinib 1Specimen Handling 1STA 9090 1Razoxane 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Neurofibrosarcoma × Everolimus × Clear all
NCT01661283 2019-03-06

SARC016: Study of Everolimus With Bevacizumab to Treat Refractory Malignant Peripheral Nerve Sheath Tumors

Sarcoma Alliance for Research through Collaboration

Phase 2 Completed
25 enrolled 15 charts
Sarcoma

Sarcoma, Neurofibrosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡